Contraindications, Drug

Agenda 2019-2022 per l’allattamento

R. Davanzo

2019/4 — pag. 237-241

The Italian Paediatric Societies recommend breastfeeding as the nutritional norm, unless an informed choice of mothers or an acceptable medical reason for formula feeding exists. Disappointingly, the 2014 Survey on Breastfeeding in Italy conducted ...

Sicurezza ed efficacia dei mucolitici in età pediatrica

L. Tartaglia, F. Trotta e i componenti del Working Group Pediatrico dell’AIFA

2011/2 — pag. 110-113

Following a signal from France, which showed an increase in the cases of bronchial obstruction and worsening respiratory disorders in children under 2 years of age treated with mucolytics, the Italian Drug Agency (AIFA) has revised the risk/benefit...

Vaccino anti-morbillo-parotite-rosolia e allergia all’uovoFinalmente una svolta epocale

I. Berti, G. Longo

2010/1 — pag. 36-40

Since measles and mumps components used in measles-mumps-rubella (MMR) vaccine are grown in cultures of fibroblast from chick embryos, the safety of administering MMR vaccine to patients allergic to eggs has been debated for long time. Finally inte...

Timerosal e vaccini: attenzione a fare le cose solo “per sicurezza”Progetto “Bambini e bambine costruttori di pace”: risultati conseguitiConclusa a livello europeo revisione NimesulideNarlisim bambini gocce nasali: controindicazione al di sotto di 12 anni di eta’ e modifica del regime di fornituraL’Oms sottolinea l’urgenza di garantire la sicurezza dei farmaci per l’infanzia

a cura Irene Bruno

2007/8